NexturnBioscience Total Debt vs. Revenue
| 089140 Stock | KRW 3,135 235.00 6.97% |
For NexturnBioscience profitability analysis, we use financial ratios and fundamental drivers that measure the ability of NexturnBioscience to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well NexturnBioscience Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between NexturnBioscience's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of NexturnBioscience Co over time as well as its relative position and ranking within its peers.
NexturnBioscience |
NexturnBioscience Revenue vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining NexturnBioscience's current stock value. Our valuation model uses many indicators to compare NexturnBioscience value to that of its competitors to determine the firm's financial worth. NexturnBioscience Co is the top company in total debt category among its peers. It also is the top company in revenue category among its peers totaling about 7.76 of Revenue per Total Debt. Comparative valuation analysis is a catch-all model that can be used if you cannot value NexturnBioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NexturnBioscience's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.NexturnBioscience Total Debt vs. Competition
NexturnBioscience Co is the top company in total debt category among its peers. Total debt of Machinery industry is presently estimated at about 183.54 Billion. NexturnBioscience claims roughly 2.19 Billion in total debt contributing just under 2% to all equities under Machinery industry.
NexturnBioscience Revenue vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
NexturnBioscience |
| = | 2.19 B |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
NexturnBioscience |
| = | 16.97 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
NexturnBioscience Revenue vs Competition
NexturnBioscience Co is the top company in revenue category among its peers. Market size based on revenue of Machinery industry is presently estimated at about 1.9 Trillion. NexturnBioscience maintains roughly 16.97 Billion in revenue contributing less than 1% to all equities under Machinery industry.
NexturnBioscience Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in NexturnBioscience, profitability is also one of the essential criteria for including it into their portfolios because, without profit, NexturnBioscience will eventually generate negative long term returns. The profitability progress is the general direction of NexturnBioscience's change in net profit over the period of time. It can combine multiple indicators of NexturnBioscience, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
,Ltd. develops and produces CNC automatic lathe machines in Korea and internationally. ,Ltd. was founded in 2000 and is based in Yongin, South Korea. NEXTURNBIO is traded on Korean Securities Dealers Automated Quotations in South Korea.
NexturnBioscience Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on NexturnBioscience. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of NexturnBioscience position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the NexturnBioscience's important profitability drivers and their relationship over time.
Use NexturnBioscience in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NexturnBioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NexturnBioscience will appreciate offsetting losses from the drop in the long position's value.NexturnBioscience Pair Trading
NexturnBioscience Co Pair Trading Analysis
The ability to find closely correlated positions to NexturnBioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NexturnBioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NexturnBioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NexturnBioscience Co to buy it.
The correlation of NexturnBioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NexturnBioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NexturnBioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NexturnBioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your NexturnBioscience position
In addition to having NexturnBioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Stores Thematic Idea Now
Stores
Companies providing different types of retail and wholesale services. The Stores theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Stores Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in NexturnBioscience Stock
To fully project NexturnBioscience's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of NexturnBioscience at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include NexturnBioscience's income statement, its balance sheet, and the statement of cash flows.